Literature DB >> 3082573

Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.

P Hainaut, E Lavenne, J M Magy, E G Lebacq.   

Abstract

We report the case of a young woman, with mixed connective tissue disease (MCTD), associated with disabling pulmonary hypertension and presence of the "lupus anticoagulant". The "lupus anticoagulant", an antibody directed against phospholipid components, was linked in our patient to extensive thrombophlebitis and premature labor. Raynaud's phenomenon progressed towards finger necrosis in spite of optimal vasodilating treatment. The part played by the "lupus anticoagulant" in pulmonary hypertension remains to be established. Both these complications responded to prednisolone therapy, but the improvement was limited and short-lived.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082573     DOI: 10.1007/bf02030976

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  Raynaud syndrome.

Authors:  R J Blunt; J M Porter
Journal:  Semin Arthritis Rheum       Date:  1981-05       Impact factor: 5.532

2.  Possible relationship between lupus inhibitor and recurrent abortion in young women.

Authors:  B G Firkin; M A Howard; N Radford
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

3.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

4.  Pulmonary hypertension in systemic lupus erythematosus.

Authors:  R A Asherson; C G Mackworth-Young; M L Boey; R G Hull; A Saunders; A E Gharavi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

5.  A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

Authors:  W D Sullivan; D J Hurst; C E Harmon; J H Esther; G A Agia; J D Maltby; S B Lillard; C N Held; J F Wolfe; E V Sunderrajan
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

6.  Raynaud's phenomenon of the lung.

Authors:  P J Fahey; M J Utell; J J Condemi; R Green; R W Hyde
Journal:  Am J Med       Date:  1984-02       Impact factor: 4.965

7.  Severe pulmonary involvement in mixed connective tissue disease.

Authors:  J P Wiener-Kronish; A M Solinger; M L Warnock; A Churg; N Ordonez; J A Golden
Journal:  Am Rev Respir Dis       Date:  1981-10

8.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

9.  Anticentromere antibody and primary pulmonary hypertension.

Authors:  J R Seibold; M C Trontell
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

10.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more
  6 in total

Review 1.  Pulmonary hypertension, antiphospholipid antibodies, and syndromes.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

2.  Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.

Authors:  R A Asherson; A G Benbow; C J Speirs; N Jackson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

Review 3.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

4.  Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

5.  Arterial thrombotic manifestations in young women associated with the lupus anticoagulant.

Authors:  E J Ter Borg; J Van der Meer; J T De Wolf; M H Van Leeuwen; C G Kallenberg
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

6.  Large leg ulcers due to autoimmune diseases.

Authors:  Alexander P Rozin; Dana Egozi; Yehuda Ramon; Kohava Toledano; Yolanda Braun-Moscovici; Doron Markovits; Daniel Schapira; Reuven Bergman; Yehuda Melamed; Yehuda Ullman; Alexandra Balbir-Gurman
Journal:  Med Sci Monit       Date:  2011-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.